NCT06886724

Investigating the Efficacy of Probiotics in Enhancing Gastrointestinal and Immunological Health

A Study on the Role of Ligilactobacillus Salivarius LS97 in Modulating Gut Microbiota and Immune System Function

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Wecare Probiotics Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

Evaluate the effectiveness and safety of Ligilactobacillus salivarius LS97 as a food supplement compared to a placebo in improving intestinal and immune functions in healthy adults.

Conditions

• Intestinal and Lmmune Function Lmproved

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Probiotic	The trial period of this study lasts for 2 months (8 weeks), during which each participant will have 3 visits (at month 0, month 1, and month 2).
DIETARY_SUPPLEMENT	Placebo	The trial period of this study lasts for 2 months (8 weeks), during which each participant will have 3 visits (at month 0, month 1, and month 2).

Timeline

• Start date: 2025-03-10
• Primary completion: 2025-09-30
• Completion: 2025-12-30
• First posted: 2025-03-20
• Last updated: 2025-03-20

Locations

1 site across 1 country: China